Literature DB >> 4180385

Cardiac toxicity of daunorubicin.

G Bonadonna, S Monfardini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4180385

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

2.  Daunorubicin and the heart.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

3.  [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].

Authors:  P Obrecht; H Merker; H H Hennekeuser; G Meuret; M Westerhausen; A Simon
Journal:  Klin Wochenschr       Date:  1970-11-01

4.  Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.

Authors:  M A Mir
Journal:  Br Heart J       Date:  1978-07

Review 5.  Different anthracycline derivates for reducing cardiotoxicity in cancer patients.

Authors:  Elvira C van Dalen; Erna Mc Michiels; Huib N Caron; Leontien Cm Kremer
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

6.  Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts.

Authors:  E Bachmann; E Weber; G Zbinden
Journal:  Agents Actions       Date:  1975-10

Review 7.  From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.

Authors:  Metin Kurtoglu; Theodore J Lampidis
Journal:  Mol Nutr Food Res       Date:  2009-01       Impact factor: 5.914

Review 8.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.

Authors:  Brian C Jensen; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533

9.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Adriamycin-induced leakage of lysosomal enzymes in vitro.

Authors:  P K Singal; B MacLeod; C M Deally
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.